A Patient Decision Aid for Psoriasis Based on Current Clinical Practice Guidelines

作者：Tan Jerry^*; Wolfe Barat

来源：Archives of Dermatology, 2012, 148(6): 718-723.

DOI：10.1001/archdermatol.2012.36

Objective: To develop a patient decision aid (PDA) for psoriasis with content derived from current clinical practice guidelines. %26lt;br%26gt;Design: This PDA was developed in accordance with international patient decision aid standards. Primary sources of treatment outcome information were English-language, evidence-based clinical practice guidelines for plaque psoriasis published between January 1, 2006, and December 31, 2010. %26lt;br%26gt;Setting: Patients with psoriasis from a private practice in Windsor, Ontario, Canada, and a focus group of dermatologists across Canada. %26lt;br%26gt;Participants: Focus groups of dermatologists (n = 5) and patients with psoriasis (n = 7) were convened to provide feedback on balance, clarity, practicality, and items for inclusion and exclusion. %26lt;br%26gt;Main Outcome Measures: Physician%26apos;s global assessment, overall lesional assessment, and 75% reduction in Psoriasis Area and Severity Index. %26lt;br%26gt;Results: Efficacy measures selected to reflect good control in the PDA were physician%26apos;s global assessment (clear or almost clear) or overall lesional assessment (none or very mild) for topical agents and 75% reduction in Psoriasis Area and Severity Index for phototherapy and systemic agents. Where available, outcomes for serious adverse effects were displayed figuratively with efficacy measures. Deliberative questions for self-completion and a values clarification exercise were also incorporated. %26lt;br%26gt;Conclusion: This psoriasis PDA was developed according to international standards based on content derived from current clinical practice guidelines.

• 出版日期2012-6